Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease

International Journal of Dermatology

Volumn 51, Issue 3, 2012, Pages 286-289

  Kato, Yasunobu ^a   Yamamoto, Toshiyuki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; GROWTH RELATED ONCOGENE ALPHA; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA NODOSUM; FEMALE; GENITAL ULCER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NAUSEA AND VOMITING; PATHOGENESIS; PUSTULE; SYMPTOM;

ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; CHEMOKINE CXCL1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84863172627     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.04998.x     Document Type: Article

References (16)

1. Hirohata S, Kikuchi H. Behçet's disease. Arthritis Res Ther 2003; 5: 139-146.
2. Koch AE, Kunkel SL, Shah MR, et al. Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995; 155: 3660-3666.
3. Kojima T, Cromie MA, Fisher GJ, et al. GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes. J Invest Dermatol 1993; 101: 767-772.
4. Furuse S, Fujii H, Kaburagi Y, et al. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis. J Rheumatol 2003; 30: 1524-1528.
5. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-1080.
6. Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behçet's disease activity index. Rheumatology 2004; 43: 73-78.
7. Wang LM, Kitteringham N, Mineshita S, et al. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease. Arch Dermatol Res 1997; 289: 444-447.
8. Zouboulis CC, Katsantonis J, Ketteler R, et al. Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 2000; 292: 279-284.
9. Evereklioglu C, Er H, Türköz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Mediators Inflamm 2002; 11: 87-93.
10. Gür-Toy G, Lenk N, Yalcin B, et al. Serum interleukin-8 as a serologic marker of activity in Behçet's disease. Int J Dermatol 2005; 44: 657-660.
11. Aki T, Karincaoglu Y, Seyhan M, Batcioglu K. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity. Clin Exp Dermatol 2006; 31: 583-587.
12. Durmazlar SP, Ulkar GB, Eskioglu F, et al. Significance of serum interleukin-8 levels in patients with Behçet's disease: high levels may indicate vascular involvement. Int J Dermatol 2009; 48: 259-264.
13. Ozoran K, Aydintuǧ O, Tokgöz G, et al. Serum levels of interleukin-8 in patients with Behcet's disease. Ann Rheum Dis 1995; 54: 610.
14. Bozkurt N, Kazokoglu H, Yavuz S, et al. Elevated serum chemokine levels in Behçet's disease with uveitis. Rheumatol Int 2003; 23: 268-269.
15. Sun A, Wang YP, Chia JS, et al. Treatment with levamisole and colchicines can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease. J Oral Pathol Med 2009; 38: 401-405.
16. Razao I, Shaoping X, Kang-Yun L, et al. GRO-α regulation in airway smooth muscle by IL-1β and TNF-α: role of NF-kB and MAP kinases. Am J Physiol Lung Cell Mol Physiol 2006; 291: L66-L74.